Clinical and bacteriological response to treatment of clinical mastitis with one of three intramammary antibiotics

New Zealand Veterinary Journal

Volumn 55, Issue 4, 2007, Pages 161-170

  McDougall, S ^a   Arthur, D G ^b   Bryan, M A ^c   Vermunt, J J ^d   Weir, A M ^e  

^a Animal Health Centre Morrinsville   (New Zealand)

^b Selwyn Rakaia Vet Services   (New Zealand)

^c Central Southland Veterinary Services   (New Zealand)

^d Awapuni Veterinary Services Ltd   (New Zealand)

^e Eltham District Veterinary Service   (New Zealand)

Author keywords

Antibiotic; Bacteriological cure; Clinical cure; Clinical mastitis; Dairy cattle; Prevalence; Therapy

Indexed keywords

ANTIINFECTIVE AGENT; CEFUROXIME; DIHYDROSTREPTOMYCIN; PROCAINE PENICILLIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG COMBINATION; FEMALE; MICROBIOLOGY; MILK; NEW ZEALAND; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; STATISTICAL MODEL; STREPTOCOCCUS INFECTION; TIME; TREATMENT OUTCOME; UDDER;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CEFUROXIME; DIHYDROSTREPTOMYCIN SULFATE; DRUG THERAPY, COMBINATION; FEMALE; LINEAR MODELS; LOGISTIC MODELS; MAMMARY GLANDS, ANIMAL; MASTITIS, BOVINE; MILK; NEW ZEALAND; PENICILLIN G, PROCAINE; RECURRENCE; STREPTOCOCCAL INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS; FRIESIA; STREPTOCOCCUS UBERIS;

EID: 34548047228     PISSN: 00480169     EISSN: 11760710     Source Type: Journal    
DOI: 10.1080/00480169.2007.36762     Document Type: Article

References (35)

1. Anonymous. A Review of the Impact of the Use of Antimicrobials in Animals and Plants on the Development of Antimicrobial Resistance in Human Bacterial Pathogens. Report of the Expert Panel on Antibiotic Resistance. http://www.nzfsa.govt.nz/acvm/subject/antibiotic-resistance/report-july-2005/expert- panel-report-2005.pdf (accessed 28 May 2007). New Zealand Food Safety Authority, Wellington, NZ, 2005
2. Anonymous. 2004–2005 New Zealand Dairy Statistics. www.lic.co.nz/113_8.cfm (accessed 28 May 2007). Livestock Improvement Corporation, Hamilton, NZ, 2006
3. Barkema HW, Schukken YH, Lam TJGM, Beiboer ML, Wilmink H, Benedictus G, Brand A. Incidence of clinical mastitis in dairy herds grouped in 3 categories by bulk milk somatic cell counts. Journal of Dairy Science 81, 411–9, 1998
4. Barkema HW, Schukken YH, Lam TJ, Beiboer ML, Benedictus G, Brand A. Management practices associated with the incidence rate of clinical mastitis. Journal of Dairy Science 82, 1643–54, 1999 a
5. Barkema HW, Van der Ploeg JD, Schukken YH, Lam TJ, Benedictus G, Brand A. Management style and its association with bulk milk somatic cell count and incidence rate of clinical mastitis. Journal of Dairy Science 82, 1655–63, 1999 b
6. Bartlett PC, Miller GY, Lance SE, Heifer LE. Environmental and managerial determinants of somatic cell counts and clinical mastitis incidence in Ohio herds. Preventive Veterinary Medicine 14, 195–207, 1992
7. Bauman DE, Currie WB. Partitioning of nutrients during pregnancy and lactation: a review of mechanisms involving homeostasis and homeorhesis. Journal of Dairy Science 63, 1514–29, 1980
8. Beaudeau F, Fourichon C. Estimating relative risk of disease from outputs of logistic regression when the disease is not rare. Preventive Veterinary Medicine 36, 243–56, 1998
9. Craven N. Efficacy and financial value of antibiotic treatment of bovine clinical mastitis during lactation: A review. British Veterinary Journal 143, 410–22, 1987
10. Dohoo IR, Martin SW Stryhn H. Veterinary Epidemiologic Research. AVC Inc, Charlottetown, Prince Edward Island, Canada, 2003
11. Elbers ARW, Miltenburg JD, De Lange D, Crauwels APP, Barkema HW, Schukken YH. Risk factors for clinical mastitis in a random sample of dairy herds from the southern part of the Netherlands. Journal of Dairy Science 81, 420–6, 1998
12. Elliott REW. Antibiotic resistance amongst haemolytic staphylococci isolated from bovine milk samples in New Zealand. New Zealand Veterinary Journal 19, 95–9, 1971
13. Faull WB, Ward WR. Treatment of clinical mastitis: Two intramammary formulations compared. Veterinary Record 96, 127–9, 1975
14. Grinberg A, Lopez-Villalobos N, Lawrence K, Nulsen M. Prediction of penicillin resistance in Staphylococcus aureus isolates from dairy cows with mastitis, based on prior test results. New Zealand Veterinary Journal 53, 332–5, 2005
15. Hodges RT, Jones YS, Holland JTS. Characterization of staphylococci associated with clinical and subclinical bovine mastitis. New Zealand Veterinary Journal 32, 141–5, 1984
16. Jarp J, Bugge HP, Larsen S. Clinical trial of three therapeutic regimens for bovine mastitis. Veterinary Record 124, 603–34, 1989
17. Lescourret F, Coulon JB, Faye B. Predictive model of mastitis occurrence in the dairy cow. Journal of Dairy Science 78, 2167–77, 1995
18. McDougall S. Efficacy of two antibiotic treatments in curing clinical and subclinical mastitis in lactating dairy cows. New Zealand Veterinary Journal 46, 226–32, 1998
19. McDougall S. Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin. New Zealand Veterinary Journal 51, 111–6, 2003
20. Milner P, Page KL, Hillerton JE. The effects of early antibiotic treatment following diagnosis of mastitis detected by a change in the electrical conductivity of milk. Journal of Dairy Science 80, 859–63, 1997
21. Peeler EJ, Green MJ, Fitzpatrick JL, Morgan KL, Green LE. Risk factors associated with clinical mastitis in low somatic cell count British dairy herds. Journal of Dairy Science 83, 2646–72, 2000
22. Prescott JF, Baggot JD, Walker RD. Antimicrobial Therapy in Veterinary Medicine. Iowa State Press, Ames IA, USA, 2000
23. Roberson JR, Warnick LD, Moore G. Mild to moderate clinical mastitis: Efficacy of intramammary amoxicillin, frequent milk-out, a combined intramammary amoxicillin, and frequent milk-out treatment versus no treatment. Journal of Dairy Science 87, 583–92, 2004
24. Salmon SA, Watts JL, Aarestrup FM, Pankey JW, Yancey RJ Jr. Minimum inhibitory concentrations for selected antimicrobial agents against organisms isolated from the mammary glands of dairy heifers in New Zealand and Denmark. Journal of Dairy Science 81, 570–8, 1998
25. Schukken YH, Deluyker HA. Design of field trials for the evaluation of antibacterial products for therapy of bovine clinical mastitis. Journal of Veterinary Pharmacology and Therapeutics 18, 274–83, 1995
26. Schukken YH, Grommers FJ, van de Geer D, Brand A. Incidence of clinical mastitis on farms with low somatic cell counts in bulk milk. Veterinary Record 125, 60–4, 1989
27. Schukken YH, Grommers FJ, van de Geer D, Erb HN, Brand A. Risk factors for clinical mastitis in herds with a low bulk milk somatic cell count. 2. Risk factors for Escherichia coli and Staphylococcus aureus. Journal of Dairy Science 74, 826–32, 1991
28. Smith KL, Todhunter DA, Schoenberger PS. Environmental pathogens and intramammary infection during the dry period. Journal of Dairy Science 68, 402–17, 1985
29. Sol S, Sampimon OC, Barkema HW, Schukken YH. Factors associated with cure after therapy of clinical mastitis caused by Staphylococcus aureus. Journal of Dairy Science 83, 278–84, 2000
30. Suriyasathaporn W, Heuer C, Noordhuizen-Stassen EN, Schukken YH. Hyperketonemia and the impairment of udder defence: a review. Veterinary Research 31, 397–412, 2000
31. Waage S, Sviland S, Odegaard SA. Identification of risk factors for clinical mastitis in dairy heifers. Journal ofDairy Science 81, 1275–84, 1998
32. Whittem T, Gaon D. Principl es of antimicrobial therapy. Veterinary Clinics of North America: Small Animal Practice 28, 197–213, 1998
33. Whittem T, Hanlon D. Dihydrostreptomycin or streptomycin in combination with penicillin G in dairy cattle therapeutics: a review and re-analysis of published data Part 2: Resistance and residues. New Zealand Veterinary Journal 45, 223–9, 1997
34. Wilesmith JW, Frances PG, Wilson CD. Incidence of clinical mastitis in a cohort of British dairy herds. Veterinary Record 118, 199–204, 1986
35. Wraight MD. A comparative efficacy trial between cefuroxime and cloxacillin as intramammary treatments for clinical mastitis in lactating cows on commercial dairy farms. New Zealand Veterinary Journal 51, 26–32, 2003